• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHADS-VASC Score and How to Predict.

作者信息

Veselka Josef

机构信息

Department of Cardiology, Motol University Hospital and 2nd Medical School, Charles University, Prague, Czech Republic.

出版信息

Can J Cardiol. 2019 Dec;35(12):1629-1630. doi: 10.1016/j.cjca.2019.07.004. Epub 2019 Jul 10.

DOI:10.1016/j.cjca.2019.07.004
PMID:31548099
Abstract
摘要

相似文献

1
Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHADS-VASC Score and How to Predict.肥厚型心肌病发生血栓栓塞事件的风险增加：CHADS-VASC评分的不足及预测方法
Can J Cardiol. 2019 Dec;35(12):1629-1630. doi: 10.1016/j.cjca.2019.07.004. Epub 2019 Jul 10.
2
CHADS-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.CHADS-VASc评分：无房颤的植入式监测装置患者血栓栓塞事件和死亡率的预测指标
Mayo Clin Proc. 2017 Mar;92(3):360-369. doi: 10.1016/j.mayocp.2016.10.008.
3
CHADS-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer.CHA2DS2-VASc 评分与伴有近期癌症的心房颤动患者的血栓栓塞和出血风险。
Eur J Prev Cardiol. 2018 Apr;25(6):651-658. doi: 10.1177/2047487318759858. Epub 2018 Feb 27.
4
Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy.肥厚型心肌病、非瓣膜性心房颤动、CHA2DS2-VASc评分≤1且未接受抗凝治疗患者的缺血性卒中和全身性栓塞发生率。
Heart Vessels. 2016 Jul;31(7):1148-53. doi: 10.1007/s00380-015-0718-5. Epub 2015 Aug 1.
5
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.CHA2DS2-VASc评分为1分的年轻男性房颤患者可能无需抗凝治疗：一项基于全国人口的研究
PLoS One. 2016 Mar 17;11(3):e0151485. doi: 10.1371/journal.pone.0151485. eCollection 2016.
6
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.CHADS2与CHA2DS2-VASc对心房颤动患者独立于抗凝治疗的中风和血栓栓塞预测的荟萃分析。
Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb.
7
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
8
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分（CHADS2、CHA2DS2-VASc 和 R2CHADS2）与心房颤动导管消融术后血栓栓塞事件风险：莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
9
Relation of red blood cell distribution width with CHADS and CHADS-VASc score in Chinese patients with non-valvular atrial fibrillation.中国非瓣膜性心房颤动患者红细胞分布宽度与CHADS及CHADS-VASc评分的关系
Int J Cardiol. 2017 Feb 1;228:861-864. doi: 10.1016/j.ijcard.2016.11.255. Epub 2016 Nov 14.
10
Should Every Patient With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 Be Anticoagulated? A Systematic Review of 37,030 Patients.是否所有 CHA2DS2-VASc 评分为 1 分的房颤患者都应抗凝？37030 例患者的系统评价
Cardiol Rev. 2019 Sep/Oct;27(5):249-255. doi: 10.1097/CRD.0000000000000246.

引用本文的文献

1
Thromboembolism in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的血栓栓塞症。
Int J Med Sci. 2021 Jan 1;18(3):727-735. doi: 10.7150/ijms.50167. eCollection 2021.